Pharmaceutical
September 2018
David Pyott: The Battle for Allergan (A)
By Lisa Duke, Randall Peterson
This case series charts the evolution of the hostile battle for Allergan and its ultimate sale to a white knight, Actavis. David Pyott had been the CEO of Allergan since January 1998; only the third CEO in the companyā€™s 60-year-plus history. Allergan was primarily known for Botox, the aesthetic an...